Why the study?
Nitrous oxide use is increasing and associated with physical and mental problems, but there is no consensus on whether it has addictive potential.
Does recreational nitrous oxide use lead to DSM-5 substance use disorder symptoms?
Does recreational nitrous oxide use lead to DSM-5 substance use disorder symptoms?
Nitrous oxide exhibits potentially addictive properties, meeting at least four DSM-5 substance use disorder criteria in heavy users, suggesting it should be treated as a potentially addictive substance.
Evidence for N2O addiction limited but consistent for several criteria; leaves open systematic prevalence data and clinical guidance.
Background Prevalence of nitrous oxide (N 2 O) use appears to be increasing in numerous countries worldwide, and excessive use has been associated with physical and mental problems. Because there currently is no consensus whether N 2 O has addictive potential, we aimed to evaluate the evidence for the presence and prevalence of DSM‐5 substance use disorder (SUD) symptoms in N 2 O users. Analysis A literature search was conducted to assess the evidence for the presence of any of the 11 DSM‐5 SUD symptoms in N 2 O users and the prevalence experiencing those symptoms. A substantial part of the studied N 2 O users use more than intended (i.e. 46% to 98%) and spend a substantial amount of time using N 2 O. At least some of the studied N 2 O users experience interpersonal problems (i.e. 13% to 80%) and use N 2 O in risky situations, such as driving under the influence. Evidence for the other criteria is either insufficient or inconclusive. Conclusions The literature base for the presence and prevalence of DSM‐5 substance use disorder (SUD) symptoms in nitrous oxide (N 2 O) users is limited and largely consists of qualitative studies and case studies, but it provides consistent evidence for the presence of at least four SUD criteria in heavy N 2 O users. N 2 O could well be addictive and should be treated as a potentially addictive substance until systematic assessments can provide evidence‐based guidance to users, healthcare professionals and legislators.
No takes yet. Share an insight, caveat, or question.
Back et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: